Search results
‘Kalki 2898 AD’: The Prabhas and Deepika Padukone starrer expected to get an OTT release in...
The Times of India· 54 minutes agoPrabhas-starrer ‘Kalki 2898 AD’ has been making a significant impact at the box office since its...
The Joe versus Donald contest: A Hobson’s choice for presidency
Firstpost· 4 hours agoSince 2016, the United States (US) has been caught in a vortex of polarisation, the gradual loss of...
After Smashing Box Office Records, Kalki 2898 AD To Release On This OTT Platform - News18
News18· 4 hours agoPrabhas-starrer Kalki 2898 AD is creating havoc at the box office. The epic sci-fi film is directed...
Emcure Pharma closes 3% higher after making strong market debut; should you buy the stock now? |...
Livemint· 5 hours agoEmcure Pharma’s IPO saw strong investor interest, with oversubscription rates of 67.87 times....
Kalki 2898 AD: A Look At Prabhas-Deepika Padukone's Film's Box Office Run (So Far)
NDTV· 7 hours agoKalki 2898 AD has emerged as the biggest box office opener of 2024, breaking records across...
South Eastern Railway: RVNL wins bid for power system upgrade project on Kharagpur-Bhadrak Rail...
Financial Express· 9 hours agoThe contract, costing about Rs 203 crore, is expected to be completed in 18 months.
Stock market update: Nifty Pharma index falls 1.01% in a weak market
The Economic Times· 10 hours agoThe Nifty Pharma index was trading 1.01 per cent down at 20437.85.
Emcure Pharma lists at 31% premium; should you buy, sell or hold the stock?
Business Standard India· 10 hours agoEmcure Pharmaceuticals listing today: According to analysts, Emcure Pharma is quoting at a...
Emcure Pharma listing: Stock makes solid debut on NSE, BSE with 31% premium
Business Standard India· 10 hours agoEmcure Pharmaceuticals listing: Stock made a strong market debut as they got listed at Rs 1,325, a...
Emcure Pharmaceuticals Lists at 31% Premium on the Bourses | India Infoline
India Infoline· 10 hours agoThe IPO comprised a mix of fresh equity sale and an offer for sale (OFS).